Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Placebo Interventions in General Practice
This study has been completed.
Sponsors and Collaborators: University of Zurich
Swiss Academy of Medical Sciences (SAMW)
Horten-Center, University Hospital of Zurich
Information provided by: University of Zurich
ClinicalTrials.gov Identifier: NCT00603928
  Purpose

Physicians often have an ambivalent relationship to placebo interventions. On the one hand they know of the intriguing effect of sugar pills or saline infusions but on the other hand they mostly feel constrained to adopt scientifically proven, specific therapies for ethical reasons. Against the background of international literature one can assume that also Swiss general practitioners use several forms of placebo interventions in a significant part of their patients.

The aim of the project is to ascertain to which extent and in which way Swiss general practitioners make use of placebo interventions. Furthermore knowledge of the mode of action of placebo interventions and the perceived moral and lawful permissibility of placebo interventions and the presumed attitudes of the patients will be investigated.

The empicical core of the study is a questionnaire survey of general practitioners in urban and rural areas of Switzerland. The results and conclusions of the survey will be discussed during a workshop with interested GPs, researchers and ethicists.

The obtained data will lead to a better understanding of the application of placebo interventions in the general practice in Switzerland (how often and in which manner, accompanied by what information, for which diseases and for which patient groups placebos are applied). Moreover the study will help to articulate potential moral ambiguities of physicians using placebo interventions.


Condition
General Practitioners

U.S. FDA Resources
Study Type: Observational
Study Design: Case-Only, Prospective
Official Title: Placebo Interventions in General Practice

Further study details as provided by University of Zurich:

Biospecimen Retention:   None Retained

Biospecimen Description:

Estimated Enrollment: 600
Study Start Date: November 2007
Study Completion Date: March 2008
Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

general practitioners and pediatricians in medical practice of the canton Zurich in Switzerland

Criteria

Inclusion Criteria:

  • general practitioners and pediatricians in medical practice of the canton Zurich in Switzerland

Exclusion Criteria:

  • no patient encounters
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00603928

Locations
Switzerland
University of Zurich
Zurich, Switzerland
Sponsors and Collaborators
University of Zurich
Swiss Academy of Medical Sciences (SAMW)
Horten-Center, University Hospital of Zurich
  More Information

Related Info  This link exits the ClinicalTrials.gov site

Responsible Party: University of Zurich, Institute for Biomedical Ethics ( Nikola Biller-Andorno )
Study ID Numbers: RRMA-5-07
Study First Received: January 16, 2008
Last Updated: November 19, 2008
ClinicalTrials.gov Identifier: NCT00603928  
Health Authority: Switzerland: Swissmedic

Keywords provided by University of Zurich:
attitude
attitude of health personnel
ethics
bioethics
biomedical ethics
patient care
physicians
placebo effect
placebos
questionnaires
therapy
general practice

ClinicalTrials.gov processed this record on January 14, 2009